Free Speech Challenges to the Inflation Reduction Act

Drug manufacturers’ First Amendment arguments against the Medicare drug price neogtiation program fail based on current Supreme Court jurisprudence. Furthermore, drug firms are allowed to challenge the Inflation Reducation Act as violating the First Amendment, this would create a much broader problem for any laws that permit the federal government to negotiate prices.